-+ 0.00%
-+ 0.00%
-+ 0.00%

Plus Therapeutics regains Nasdaq compliance with $1 minimum bid rule

PUBT·04/21/2026 11:30:24
Listen to the news
Plus Therapeutics regains Nasdaq compliance with $1 minimum bid rule
  • Nasdaq notified Plus Therapeutics that it regained compliance with Listing Rule 5550(a)(2) minimum bid price requirement.
  • Exchange determined common stock closing bid stayed at or above USD 1 for 10 consecutive business days from April 6, 2026 to April 17, 2026.
  • Nasdaq closed matter tied to prior noncompliance with minimum bid price rule.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604210730PRIMZONEFULLFEED9693275) on April 21, 2026, and is solely responsible for the information contained therein.